Development of biologically relevant, predictive cell-based assays for compound screening and toxicity assessment is a major challenge in drug discovery. See how the FLIPR® Penta and ImageXpress® Micro Confocal Systems are used to obtain robust multi-parameter cytotoxicity data.
